{"disease":{"id":"endogenous-cushing-syndrome","name":"endogenous cushing syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03277690","title":"A Study to Assess the Safety and Efficacy of Levoketoconazole in the Treatment of Endogenous Cushing's Syndrome.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":84,"lead_sponsor_name":"Cortendo AB","has_results":true},{"nct_id":"NCT06131580","title":"Canadian Continuation of Roll-over Study in Patients With Endogenous Cushing's Syndrome","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":7,"lead_sponsor_name":"Centre hospitalier de l'Université de Montréal (CHUM)","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}